Overview

Clinical Trial in Patients With Metastatic Colorectal Cancer

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
The objectives of this trial are to determine if CoFactor in combination with 5-FU are effective in the treatment of metastatic colorectal cancer and to determine the side effects observed with the administration of CoFactor and 5-FU.
Phase:
Phase 2
Details
Lead Sponsor:
Mast Therapeutics, Inc.
Collaborator:
University of California, San Diego